ClinicalTrials.Veeva

Menu

Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels (Plasti-Stim)

H

Hôpital le Vinatier

Status

Unknown

Conditions

Schizophrenia
Depression

Treatments

Device: non invasive brain stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT02652832
CSR B04

Details and patient eligibility

About

The aim of this study is to investigate the effects of non invasive brain stimulation - NIBS - techniques (Electroconvulsivotherapy - ECT, transcranial Direct Current Stimulation - tDCS, repetitive transcranial magnetic stimulation - rTMS) on serum Brain Derived Neurotrophic factor (BDNF) levels in patients with depression and schizophrenia. Four blood samples will be collected in each participants, one before the NIBS sessions, and 3 after the completion of NIBS protocols: one immediately after the end of the NIBS sessions, a second one week after and a last one month after. Two blood samples separated by one month will also be collected in a a group of healthy volunteers.

Full description

The hypothesis is that NIBS will modulate BDNF levels and that the modification in serum BDNF levels will be correlated with clinical improvements in the sample of patients.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • in the depression group: DSM IV criteria of MDD; HDRS17> 22; stage 2 of resistance; received rTMS or ECT
  • in the schizophrenia group DSM IV criteria of schizophrenia; pharmaco-resistance of symptoms (either negative symptoms or auditory verbal hallucination); received rTMS or tDCS
  • in the healthy volunteers group : to not have axis I of DSM IV diagnosis; no siblings with axis I DSM IV diagnosis

Exclusion criteria

  • less than 18 years old
  • pregnancy
  • received benzodiazepine

In the depression and schizophrenia group:

  • bipolar disorder
  • other axis I of DSM IV diagnosis (excluding for Tobacco use disorder)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

200 participants in 8 patient groups

Depression Electroconvulsive therapy
Active Comparator group
Description:
40 patients with major depression receiving a mean of 12 sessions of Electroconvulsive therapy
Treatment:
Device: non invasive brain stimulation
Depression active repetitive transcranial magnetic stimulation
Active Comparator group
Description:
40 patients with major depression receiving a mean 4 weeks of 1 Hz repetitive transcranial magnetic stimulation applied over the right dorsolateral prefrontal cortex - DLPFC
Treatment:
Device: non invasive brain stimulation
Depression sham repetitive transcranial magnetic stimulation
Sham Comparator group
Description:
40 patients with major depression receiving a mean 4 weeks of sham 1 Hz repetitive transcranial magnetic stimulation applied over the right dorsolateral prefrontal cortex - DLPFC
Treatment:
Device: non invasive brain stimulation
Schizophrenia active transcranial magnetic stimulati
Active Comparator group
Description:
40 patients with schizophrenia and predominant negative symptoms receiving 20 sessions of intermittent theta burst simulation (iTBS) applied over the left dorsolateral prefrontal cortex - DLPFC
Treatment:
Device: non invasive brain stimulation
Schizophrenia sham transcranial magnetic stimulation
Sham Comparator group
Description:
patients with schizophrenia and predominant negative symptoms receiving 20 sessions of sham intermittent theta burst simulation (iTBS) applied over the left dorsolateral prefrontal cortex - DLPFC
Treatment:
Device: non invasive brain stimulation
Schizophrenia active transcranial Direct Current Stimulation
Active Comparator group
Description:
40 patients with schizophrenia and auditory verbal hallucinations receiving 10 sessions of transcranial Direct current stimulation (tDCS) applied with the anode over the left dorsolateral prefrontal cortex - DLPFC- and the cathode over the left temporoparietal junction
Treatment:
Device: non invasive brain stimulation
Schizophrenia sham transcranial Direct Current Stimulation
Sham Comparator group
Description:
40 patients with schizophrenia and auditory verbal hallucinations receiving 10 sessions of sham transcranial Direct current stimulation (tDCS) applied with the anode over the left dorsolateral prefrontal cortex - DLPFC- and the cathode over the left temporoparietal junction
Treatment:
Device: non invasive brain stimulation
Healthy volunteers
No Intervention group
Description:
80 healthy volunteers receiving no stimulation

Trial contacts and locations

1

Loading...

Central trial contact

lydie sartelet

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems